ArticleRisk analysis : an official publication of the Society for Risk Analysis2026
Using Risk-Benefit Analysis and the Analytical Hierarchy Process to Decide on the Implementation of Rapid Salmonella Detection Methods in Large Poultry Industries.
Article in Risk analysis : an official publication of the Society for Risk Analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Tools based on multi-criteria decision analysis (MCDA) can be used in decision-making processes related to food safety issues (FSI). We used risk-benefit analysis (RBA) and the analytic hierarchy process (AHP) to answer the following questions: What are the benefits and risks of using rapid Salmonella assays in large-scale poultry industries? What are the benefits and risks of changing one implemented rapid method by another? In the RBA, we described the FSI, ranked Salmonella risk, and analyzed the benefits and costs of assays by considering seven criteria: supply capacity, international validation, cost of equipment, ease to perform, technical support, cost per sample, and time to obtain results. AHP, a mathematical framework based on pairwise comparisons, was used to confirm RBA findings. As a result, the RBA recommended the use of rapid assays in large poultry companies because they provide high benefits at low to high costs. However, the RBA was unable to identify the benefits of changing one implemented method by another because well-known methods present similar characteristics, and the decision should be based on the best business proposals. The AHP analysis confirmed that faster assays bring higher benefits and could be companies' choice, even costing more, but they have to attend to the main characteristics of well-known assays, including equipment on loan. The main criteria for choosing rapid methods were prioritized as supply capacity, technical support, time to obtain results, and international validations. RBA and AHP reached equal conclusions; however, RBA was simpler to apply, whereas AHP enabled quantitative analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.